Papillary Renal Carcinoma Presenting as a Cancer of Unknown Primary (CUP) and Diagnosed through Gene Expression Profiling.

作者: Steven M. Sorscher , Frank Anthony Greco

DOI: 10.1159/000339130

关键词:

摘要: Cancer of unknown primary (CUP) is a clinical syndrome representing many types cancers and diagnoses are typically made after review presentation, pathology (including immunohistochemical staining) imaging studies. Treatment with systemic chemotherapy has been shown to result in fairly reproducible objective response rates. Herein, case patient who was initially diagnosed poorly differentiated adenocarcinoma origin reported. After mRNA gene expression profiling (commercially available CancerTYPE ID), specific diagnosis papillary renal cell carcinoma (RCC) then confirmed additional staining. The treated targeted therapy an radiographic seen. A literature suggests this be the first RCC, identified by molecular profiling, benefitting from agent that otherwise would not have considered setting CUP. This underscores importance considering use newer testing technologies interest offering patients more specific, order improve efficacy spare toxicities less empiric chemotherapeutic regimens.

参考文章(14)
L. S. Freudenberg, S. J. Rosenbaum-Krumme, A. Bockisch, W. Eberhardt, A. Frilling, Cancer of unknown primary. Recent results in cancer research. ,vol. 170, pp. 193- 202 ,(2008) , 10.1007/978-3-540-31203-1_15
Erland Jb, Gray J, Hainsworth Jd, Burris Ha rd, Morrissey Lh, Greco Fa, Taxane-based chemotherapy for patients with carcinoma of unknown primary site. Cancer Journal. ,vol. 7, pp. 203- ,(2001)
F. Anthony Greco, Howard A. Burris, Joan B. Erland, James R. Gray, Leonard A. Kalman, Marshall T. Schreeder, John D. Hainsworth, Carcinoma of unknown primary site. Cancer. ,vol. 89, pp. 2655- 2660 ,(2000) , 10.1002/1097-0142(20001215)89:12<2655::AID-CNCR19>3.0.CO;2-9
Dimitri Talantov, Jonathan Baden, Tim Jatkoe, Kristina Hahn, Jack Yu, Yashoda Rajpurohit, Yiqiu Jiang, Chang Choi, Jeffrey S. Ross, David Atkins, Yixin Wang, Abhijit Mazumder, A Quantitative Reverse Transcriptase-Polymerase Chain Reaction Assay to Identify Metastatic Carcinoma Tissue of Origin The Journal of Molecular Diagnostics. ,vol. 8, pp. 320- 329 ,(2006) , 10.2353/JMOLDX.2006.050136
Richard A. Bender, Mark G. Erlander, Molecular Classification of Unknown Primary Cancer Seminars in Oncology. ,vol. 36, pp. 38- 43 ,(2009) , 10.1053/J.SEMINONCOL.2008.10.002
Robert J Motzer, Bernard Escudier, Stéphane Oudard, Thomas E Hutson, Camillo Porta, Sergio Bracarda, Viktor Grünwald, John A Thompson, Robert A Figlin, Norbert Hollaender, Gladys Urbanowitz, William J Berg, Andrea Kay, David Lebwohl, Alain Ravaud, None, Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial The Lancet. ,vol. 372, pp. 449- 456 ,(2008) , 10.1016/S0140-6736(08)61039-9
Gauri R Varadhachary, Dmitri Talantov, Martin N Raber, Christina Meng, Kenneth R Hess, Tim Jatkoe, Renato Lenzi, David R Spigel, Yixin Wang, F Anthony Greco, James L Abbruzzese, John D Hainsworth, None, Molecular Profiling of Carcinoma of Unknown Primary and Correlation With Clinical Evaluation Journal of Clinical Oncology. ,vol. 26, pp. 4442- 4448 ,(2008) , 10.1200/JCO.2007.14.4378
F. Anthony Greco, John D. Hainsworth, Introduction: unknown primary cancer. Seminars in Oncology. ,vol. 36, pp. 6- 7 ,(2009) , 10.1053/J.SEMINONCOL.2008.10.007
Mark G. Erlander, Xiao-Jun Ma, Nicole C. Kesty, Lei Bao, Ranelle Salunga, Catherine A. Schnabel, Performance and Clinical Evaluation of the 92-Gene Real-Time PCR Assay for Tumor Classification The Journal of Molecular Diagnostics. ,vol. 13, pp. 493- 503 ,(2011) , 10.1016/J.JMOLDX.2011.04.004
F. Anthony Greco, David R. Spigel, Denise A. Yardley, Mark G. Erlander, Xiao‐Jun Ma, John D. Hainsworth, Molecular Profiling in Unknown Primary Cancer: Accuracy of Tissue of Origin Prediction Oncologist. ,vol. 15, pp. 500- 506 ,(2010) , 10.1634/THEONCOLOGIST.2009-0328